Evidence map›Paper›PMID 29621374›Full record

Observational studyJAMA facial plastic surgery2018

Novel Use of a Volumizing Hyaluronic Acid Filler for Treatment of Infraorbital Hollows.

Michael B Hall, Sudeep Roy, Edward D Buckingham

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in JAMA facial plastic surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Fat or fillers: The dilemma in eyelid surgery.World journal of clinical cases · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Michael B HallBuckingham Center for Facial Plastic Surgery, Austin, Texas.
Sudeep RoyBuckingham Center for Facial Plastic Surgery, Austin, Texas.
Edward D BuckinghamBuckingham Center for Facial Plastic Surgery, Austin, Texas.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

importanceHyaluronic acid filler can be safely used as a soft-tissue filler for correction of infraorbital hollowing. It has a high overall patient satisfaction profile among patients.

objectiveTo report safety and patient satisfaction outcomes of Juvéderm Voluma XC for correction of infraorbital hollows. DESIGN, SETTING, AND PATIENTS: This was a retrospective observational study performed at a private ambulatory facial plastic and reconstructive surgery practice. Participants were all patients 21 to 85 years old who presented to our practice and underwent Juvéderm Voluma XC treatment for correction of infraorbital hollows as a singular intervention from February 2016 to March 2017.

interventionsInjection of Juvéderm Voluma XC to the tear trough, nasojugal fold, and/or palpebromalar groove. MAIN OUTCOMES AND MEASURES: Primary outcome measures include the number of recorded short- and long-term adverse events, need for additional treatment, and patient questionnaire FACE-Q scores.

resultsA total of 202 eyes were treated in 101 patients with a mean follow-up of 12 months. Patients were principally female (90 [89%]) with an average age of 54 years (range, 21-85 years). Most patients (99) had Fitzpatrick grade 1 to 4 skin type (98%) and had an infraorbital hollows score of 2 to 4 (89 [88%]). The average initial treatment volume was 1 mL with 18 patients (18%) requiring additional treatment within 3 months. The average time until additional treatment was 35.7 days. Adverse effects include bruising (in 10 [10%], contour irregularities (2 [2%]), swelling (3 [3%]), and Tyndall effect (1 [1%]). Hyaluronidase was required in 3 patients (3%). Forty-one patients completed the FACE-Q Satisfaction With Eyes survey, and 42 patients completed the FACE-Q Satisfaction With Decision survey (41% and 42%). Overall mean (SD) patient satisfaction (based on FACE-Q scores) was 71.1% (27.3) and 65.6% (31.3), respectively. CONCLUSIONS AND RELEVANCE: Juvéderm Voluma XC has a high patient satisfaction profile and an acceptable safety profile for the correction of infraorbital hollowing. LEVEL OF EVIDENCE: 4.

Indexed as

OrbitAdultAgedAged, 80 and overDermal FillersFemaleHumansHyaluronic AcidMaleMiddle AgedPatient SatisfactionPhotographyRetrospective StudiesSkin AgingSurveys and QuestionnairesTreatment OutcomeDermal FillersHyaluronic AcidJuvederm VOLUMAViscosupplements

Identifiers

PMID29621374
PMCPMC6233621
OpenAlexW2796007600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.